IL1B and type 2 diabetes mellitus: We propose that subjects with high-apoB may be an ideal population to target the IL-1β pathway given higher WAT IL-1β-secretion in response to both metabolic (LDL and ATP) and microbial (LPS) stimuli and higher risk for T2D in this population.